Blood Clot Knowledge Translation Research Project
Improving Venous thromboembolism (VTE) Diagnosis, Prevention, and Treatment Among Individuals with Mobility Disabilities
AAHD is the lead organization with our partners, the National Blood Clot Alliance (NBCA), the Association of Programs in Rural Independent Living (APRIL), and the National Council on Independent Living (NCIL), and two Centers for Independent Living, for the two-year VTE KTTU Project. The VTE KTTU Project is funded by the Bristol Myers Squibb Foundation. The purpose of the project is to improve the vascular health of adults with mobility disabilities as it relates to Venous thromboembolism (VTE). VTE is a condition in which a blood clot forms and creates a hazardous and potentially deadly medical condition, especially for persons with mobility disabilities who are at high risk for VTE.
The VTE KTTU Project is a multi-site pilot embedded case study in one rural and one urban location to assess the impact of customized knowledge translation, transfer, and utilization (KTTU) activities in facilitating increases in VTE awareness and knowledge, patient activation, and clinical outcomes (diagnostic testing, preventive services, and treatment) among adults with mobility disabilities. The three target audiences are adults with mobility disabilities, direct care workers such as personal care attendants, and health care providers in two geographic locations. A special panel consisting of health experts, disability advocates, and health care providers and insurance experts is assisting the project in converting VTE research findings into actionable forms for specific end users (translation), and advising the project on disseminating the modified findings (transfer) and subsequent use of the modified findings (utilization).
For more information contact: Charles E. Drum, MPA, JD, PhD at firstname.lastname@example.org or (301) 545-6140, Extension 205.
This project is funded by the Bristol Myers Squib Foundation to the American Association on Health and Disability (AAHD). This webpage content are solely the responsibility of the authors and do not necessarily represent the official views of the Bristol Myers Squib Foundation. Support Provided by: